Finance

Lists
BCCOY:OTCMKTS
BICO Group 4 ADR Representing Ord Shs
0,71 USD
0,00%
(0,00) 1D
14-окт., 12:14:14 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BCCOY...
Mkt. cap
1,68 млд
Avg. vol.
20,00
Volume
0,00
52-wk high
0,75 USD
52-wk low
0,35 USD
Beta
1,95
Shares outstanding
276,30 млн
No. of employees
554
Mkt. cap
1,68 млд
Avg. vol.
20,00
Volume
0,00
52-wk high
0,75 USD
52-wk low
0,35 USD
Beta
1,95
Shares outstanding
276,30 млн
No. of employees
554
News stories
From web sources and news partners
Profile
Bico Group is a Swedish bioconvergence company that designs and supplies technologies and services to enhance biology research. It focuses on commercializing technologies for life science research as well as bioprinting. Bico Group began by producing bio-inks and bioprinters for culturing different cell types to enable applications like patient-derived implants. Bico Group was the first company to provide a standardized bio-ink product for sale over the internet. The company has ongoing collaborations with organizations including AstraZeneca, MedImmune, MIT and Takara Bio, and its bioprinters are used for research at Harvard University, Merck, Novartis, the U.S. Army, Toyota, Johnson & Johnson and more. Wikipedia
About BICO Group 4 ADR Representing Ord Shs
CEO-
Employees554
Founded2016-ж., 27-янв.
Headquarters-
SectorHealth care
Websitebico.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
386,90 млн
451,30 млн
329,90 млн
336,10 млн
Cost of goods sold
174,20 млн
215,90 млн
151,30 млн
136,90 млн
Cost of revenue
174,20 млн
215,90 млн
151,30 млн
136,90 млн
Research and development expenses
50,10 млн
48,80 млн
49,30 млн
56,90 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
204,10 млн
204,30 млн
224,80 млн
179,70 млн
Operating expense
259,60 млн
249,50 млн
269,80 млн
229,40 млн
Total operating expenses
433,80 млн
465,40 млн
421,10 млн
366,30 млн
Operating income
-46,90 млн
-14,10 млн
-91,20 млн
-30,20 млн
Other non operating income
-
-8,40 млн
-
-100,00 миң
EBT including unusual items
-1,11 млд
-57,00 млн
-127,50 млн
-34,90 млн
EBT excluding unusual items
-73,30 млн
-73,30 млн
-105,30 млн
-23,60 млн
Income tax expense
-2,20 млн
2,20 млн
3,80 млн
2,30 млн
Effective tax rate
0,20%
-3,86%
-2,98%
-6,59%
Other operating expenses
5,40 млн
-3,60 млн
-4,30 млн
-7,20 млн
Net income
-612,70 млн
-55,00 млн
-131,30 млн
-37,20 млн
Net profit margin
-158,36%
-12,19%
-39,80%
-11,07%
Earnings per share
-
-
-
-
Interest and investment income
2,70 млн
212,00 млн
9,10 млн
20,30 млн
Interest expense
-29,10 млн
-11,90 млн
-23,20 млн
-13,60 млн
Net interest expenses
-26,40 млн
200,10 млн
-14,10 млн
6,70 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
1,04 млд
48,40 млн
-20,10 млн
27,00 млн
Gain or loss from assets sale
-
-480,30 млн
-
-
AI content may include mistakes. Learn more
Google колдонмолору